"Reperfusion Injury - Pipeline Review, H1 2013" Now Available at Fast Market Research
Global Markets Direct's, 'Reperfusion Injury - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Reperfusion Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Reperfusion Injury. Reperfusion Injury - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations...
View full press release